• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI EvidencePulse™
  • Pharma
  • AI News
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI EvidencePulse™
  • Pharma
  • AI News
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Pharma

Wegovy survey finds decline in constant food thoughts and improved well being

byDeepti Shroff Karhade
September 24, 2025
in Pharma
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

1. Survey of 550 adults found a 46 percent reduction in constant food thoughts after starting Wegovy.
2. 64 percent of participants reported improved mental well being, suggesting benefits beyond weight loss.

A survey of 550 adults presented at the European Association for the Study of Diabetes reported that constant food thoughts dropped from 62 percent to 16 percent after treatment with Wegovy. This represents a relative reduction of 46 percent. In the same study, 64 percent of participants said their mental well being improved. Novo Nordisk, which generated more than five billion dollars in Wegovy sales last year, is highlighting these findings to frame obesity treatment as both metabolic and psychological. Most respondents were middle aged women, so further studies will be needed to confirm whether the benefits extend to more diverse populations. Patients reported less “food noise,” a term increasingly used to describe intrusive mental preoccupation with eating. For physicians, the survey provides a useful counseling point: adherence may improve not just because of weight reduction but because of reduced cognitive burden. While observational data are not as rigorous as randomized trials, quality-of-life outcomes often resonate strongly with patients. These findings also align with the growing view that obesity is a multifaceted disease involving neurobiology as much as metabolism. Long-term studies will determine whether these mental health gains persist. For now, the results add a compelling narrative for patients struggling with both obesity and constant intrusive food thoughts.

Image: PD

©2025 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

RELATED REPORTS

FDA escalates warning letters over misleading drug advertising

What Is the Cricothyroid Membrane and Why It Matters in Medicine

2 Minute Medicine: Pharma Roundup: Enbumyst Nasal Spray Approval, FDA Targets Drug Ads, Samsung BioLogics Contract, Wegovy Mental Health Benefits [September 17 2025]

Tags: hungermental healthmetabolismneurobiologyobesitywegovyweight loss
Previous Post

The association of the planetary health diet with type 2 diabetes incidence and greenhouse gas emissions: Findings from the EPIC-Norfolk prospective cohort study

RelatedReports

FDA-regulated clinical trials rarely report violations
Pharma

FDA escalates warning letters over misleading drug advertising

September 19, 2025
Patient Basics: Graves’ Disease
Career Development

What Is the Cricothyroid Membrane and Why It Matters in Medicine

September 17, 2025
2 Minute Medicine: Pharma Roundup: Price Hikes, Breakthrough Approvals, Legal Showdowns, Biotech Expansion, and Europe’s Pricing Debate [May 12nd, 2025]
Cardiology

2 Minute Medicine: Pharma Roundup: Enbumyst Nasal Spray Approval, FDA Targets Drug Ads, Samsung BioLogics Contract, Wegovy Mental Health Benefits [September 17 2025]

September 17, 2025
Increased number of daily steps linked with decreased mortality in older women
Endocrinology

Semaglutide and tirzepatide may be cost-effective for knee osteoarthritis in patients with obesity

September 15, 2025

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Wegovy survey finds decline in constant food thoughts and improved well being
  • The association of the planetary health diet with type 2 diabetes incidence and greenhouse gas emissions: Findings from the EPIC-Norfolk prospective cohort study
  • Samsung BioLogics lands $1.3 billion U.S. contract amid tariff uncertainty
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2025 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI EvidencePulse™
  • Pharma
  • AI News
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
No Result
View All Result

© 2025 2 Minute Medicine, Inc. - Physician-written medical news.